Strand Therapeutics
Programmable mRNA
Strand Therapeutics is a 51-200-employee Biotechnology Research company based in Cambridge, Massachusetts. Founded in 2017. Has raised $153M, most recently at the Series B stage. Its most recent round on file is dated Aug 7, 2025. Adamlead has 1 contact on file at Strand Therapeutics.
Company details
Tech stack
Not on file.
People at Strand Therapeutics
| Name | Title | |
|---|---|---|
Jacob Becraft | Co-Founder and CEO | j***@strandtx.comVerified |
Companies similar to Strand Therapeutics
Frequently asked questions
When did Strand Therapeutics last raise funding?+
Strand Therapeutics's most recent round on file is dated Aug 7, 2025, at the Series B stage. Total funding on file: $153M.
How many contacts does Adamlead have for Strand Therapeutics?+
We have 1 contact on file for Strand Therapeutics. Each email shows its verification status and a confidence score.
What industry is Strand Therapeutics in?+
Strand Therapeutics is categorized under Biotechnology Research on Adamlead, alongside 17 other companies in the segment.
Can I get verified emails for people at Strand Therapeutics?+
Yes. Start a 7-day free trial and reveal any contact's email for one credit. Every address carries a confidence score, and revealing the same contact again is always free.
What companies are similar to Strand Therapeutics?+
Other Biotechnology Research startups on Adamlead, closest first by funding stage, include Ansa Biotechnologies, AlgiSys BioSciences, Enveda. See the list below for more.
Reveal verified contacts at Strand Therapeutics
Strand Therapeutics raised on Aug 7, 2025 — reach out while the budget is fresh. 7-day free trial, no card required.
Start free trial